HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Harald Hefter Selected Research

Torticollis (Wryneck)

11/2022The complex relationship between antibody titers and clinical outcome in botulinum toxin type A long-term treated patients with cervical dystonia.
1/2022The Use of High Initial Doses of Botulinum Toxin Therapy for Cervical Dystonia Is a Risk Factor for Neutralizing Antibody Formation-A Monocentric Cross-Sectional Pilot Study.
1/2022Significant Long-Lasting Improvement after Switch to Incobotulinum Toxin in Cervical Dystonia Patients with Secondary Treatment Failure.
1/2021The Impact of SARS-CoV-2 Pandemic Lockdown on a Botulinum Toxin Outpatient Clinic in Germany.
1/2021The impact of the initial severity on later outcome: retrospective analysis of a large cohort of botulinum toxin naïve patients with idiopathic cervical dystonia.
1/2021The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia.
1/2021Clinical Improvement After Treatment With IncobotulinumtoxinA (XEOMIN®) in Patients With Cervical Dystonia Resistant to Botulinum Toxin Preparations Containing Complexing Proteins.
12/2020The Extreme Ends of the Treatment Response Spectrum to Botulinum Toxin in Cervical Dystonia.
10/2020Transient Improvement after Switch to Low Doses of RimabotulinumtoxinB in Patients Resistant to AbobotulinumtoxinA.
1/2020Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Harald Hefter Research Topics

Disease

18Torticollis (Wryneck)
11/2022 - 01/2011
11Hepatolenticular Degeneration (Wilson's Disease)
12/2021 - 12/2002
6Pain (Aches)
01/2020 - 11/2006
6Tremor (Tremors)
01/2020 - 04/2006
5Stroke (Strokes)
03/2021 - 08/2005
3Muscle Spasticity (Spastic)
03/2021 - 09/2012
3Dystonia (Limb Dystonia)
01/2021 - 01/2010
2Paralysis (Palsy)
11/2022 - 01/2019
2Peroneal Neuropathies
03/2021 - 01/2021
2Disease Progression
01/2020 - 04/2006
2Myofascial Pain Syndromes (Myofascial Pain Syndrome)
11/2011 - 11/2006
2Neurodegenerative Diseases (Neurodegenerative Disease)
04/2006 - 02/2003
1Hemiplegia (Spastic Hemiplegia)
03/2021
1Constipation
10/2020
1Muscle Hypertonia
01/2020
1Dysarthria (Spastic Dysarthria)
01/2018
1Multiple Myeloma
10/2016
1Adenocarcinoma
10/2016
1Cerebellar Ataxia (Dysmetria)
10/2016
1Neoplasms (Cancer)
10/2016
1Polyneuropathies (Polyneuropathy)
10/2016
1Paraneoplastic Polyneuropathy
10/2016
1Contracture
02/2014
1Neurologic Manifestations (Neurological Manifestations)
08/2013
1Ganglion Cysts (Ganglion)
01/2012
1Fibrosis (Cirrhosis)
01/2012
1Hypertrophy
01/2011
1Anemia
02/2007
1Prion Diseases (Transmissible Spongiform Encephalopathies)
04/2006
1Paresis (Hemiparesis)
08/2005
1Atherosclerosis
09/2004
1Mitochondrial Diseases (Mitochondrial Disease)
09/2004
1Parkinson Disease (Parkinson's Disease)
09/2004
1Iron Overload
12/2002
1Liver Diseases (Liver Disease)
12/2002
1Brain Diseases (Brain Disorder)
06/2002

Drug/Important Bio-Agent (IBA)

17Botulinum Toxins (Botulinum Toxin)IBA
01/2022 - 08/2005
15incobotulinumtoxinAFDA Link
01/2022 - 11/2006
10Type A Botulinum Toxins (Botox)FDA Link
11/2022 - 01/2011
8CopperIBA
01/2021 - 12/2002
6Neutralizing AntibodiesIBA
01/2022 - 09/2016
5abobotulinumtoxinAFDA Link
01/2020 - 11/2006
2onabotulinum toxin AIBA
11/2022 - 01/2020
2Ceruloplasmin (Ferroxidase)IBA
01/2018 - 04/2006
2Pain-FreeIBA
11/2011 - 11/2006
1Polymethyl Methacrylate (Sol)IBA
03/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1rimabotulinumtoxinBFDA Link
10/2020
1EnzymesIBA
01/2018
1AutoantibodiesIBA
10/2016
1Immunoglobulin G (IgG)IBA
10/2016
1Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA
10/2016
1Chelating AgentsIBA
08/2013
1Penicillamine (Cuprimine)FDA Link
08/2013
1Trientine (Trien)FDA Link
08/2013
1Retinaldehyde (Retinal)IBA
01/2012
1Primidone (Sertan)FDA LinkGeneric
01/2010
1Cholinergic Antagonists (Anticholinergics)IBA
01/2010
1Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
02/2007
1PhosphatidylserinesIBA
02/2007
1AcidsIBA
02/2007
1CeramidesIBA
02/2007
1Dihydrotachysterol (AT 10)IBA
11/2006
1Prion ProteinsIBA
04/2006
1Methionine (L-Methionine)FDA Link
04/2006
1Codon (Codons)IBA
04/2006
1NeurotoxinsIBA
09/2004
1Levodopa (L Dopa)FDA LinkGeneric
09/2004
1ManganeseIBA
02/2003
1Transferrin (beta 2 Transferrin)IBA
12/2002
1Ferritins (Ferritin)IBA
12/2002
1IronIBA
12/2002
1Pharmaceutical PreparationsIBA
06/2002

Therapy/Procedure

16Therapeutics
01/2022 - 01/2011
9Injections
03/2021 - 11/2006
3Aftercare (After-Treatment)
01/2021 - 11/2006
2Intramuscular Injections
05/2014 - 01/2011
1Duration of Therapy
01/2018
1Occupational Therapy (Therapy, Occupational)
02/2014
1Chelation Therapy (Therapy, Chelation)
12/2002